Association Between a Polymorphism (rs2071214) in Baculoviral IAP Repeat Containing 5 Gene (BIRC5) and Ischemic Stroke in Korean Population
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To investigate whether baculoviral inhibitor of apoptosis (IAP) repeat containing 5 gene (BIRC5) polymorphisms are associated with the development and clinical phenotypes of ischemic stroke in Korea population.Methods We enrolled 121 ischemic stroke patients and 291 control subjects. Ischemic stroke patients were divided into subgroups according to the scores of National Institutes of Health Stroke Survey (<6 or ≥6) and Modified Barthel Index (<60 or ≥60). Single nucleotide polymorphisms (SNPs) of BIRC5 (rs3764383 and rs2071214) were selected and genotyped by direct sequencing for all subjects. Multiple logistic regression models (codominant 1 and 2, dominant, recessive, overdominant and log-additive) were used to estimate odds ratios (ORs), 95% confidence intervals (CIs), and p-values.Results In analysis of stroke susceptibility, the genotype and allele frequencies of rs3764383 exhibited no difference between the control group and the ischemic stroke group. SNP rs2071214 was associated with ischemic stroke in the codominant (p=0.003), dominant (p=0.002), overdominant (p=0.005), and log-additive (p=0.008) models, respectively. The G allele frequency of rs2071214 was significantly (p=0.009) associated with susceptibility for ischemic stroke (OR, 1.57; 95% CI, 1.12–2.21). However, in the analysis for clinical phenotype, no SNP of the BIRC5 gene was found to be associated with ischemic stroke.Conclusion These results suggest that a missense SNP (rs2071214) of BIRC5 may be associated with the development of ischemic stroke in the Korean population.
Abstract
Objective To investigate whether baculoviral inhibitor of apoptosis (IAP) repeat containing 5 gene (BIRC5) polymorphisms are associated with the development and clinical phenotypes of ischemic stroke in Korea population.Methods We enrolled 121 ischemic stroke patients and 291 control subjects. Ischemic stroke patients were divided into subgroups according to the scores of National Institutes of Health Stroke Survey (<6 or ≥6) and Modified Barthel Index (<60 or ≥60). Single nucleotide polymorphisms (SNPs) of BIRC5 (rs3764383 and rs2071214) were selected and genotyped by direct sequencing for all subjects. Multiple logistic regression models (codominant 1 and 2, dominant, recessive, overdominant and log-additive) were used to estimate odds ratios (ORs), 95% confidence intervals (CIs), and p-values.Results In analysis of stroke susceptibility, the genotype and allele frequencies of rs3764383 exhibited no difference between the control group and the ischemic stroke group. SNP rs2071214 was associated with ischemic stroke in the codominant (p=0.003), dominant (p=0.002), overdominant (p=0.005), and log-additive (p=0.008) models, respectively. The G allele frequency of rs2071214 was significantly (p=0.009) associated with susceptibility for ischemic stroke (OR, 1.57; 95% CI, 1.12–2.21). However, in the analysis for clinical phenotype, no SNP of the BIRC5 gene was found to be associated with ischemic stroke.Conclusion These results suggest that a missense SNP (rs2071214) of BIRC5 may be associated with the development of ischemic stroke in the Korean population.
참고문헌 (31)
- Keun-Sik Hong, "Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke", 대한뇌졸중학회지, 15(1), pp.2~20 (2013), 대한뇌졸중학회[DOI]
- Grysiewicz RA, "Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors", Neurol Clin, 26, pp.871~895 (2008)
- Ikram MA, "Genomewide association studies of stroke", N Engl J Med, 360, pp.1718~1728 (2009)
- Lanktree MB, "Advances in genomic analysis of stroke: what have we learned and where are we headed?", Stroke, 41, pp.825~832 (2010)
- Somarajan BI, "Evaluation of MTHFR C677T polymorphism in ischemic and hemorrhagic stroke patients: a case-control study in a Northern Indian population", J Neurol Sci, 304, pp.67~70 (2011)
- Gomez-Sanchez JC, "The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke", J Exp Med, 208, pp.429~437 (2011)
- Tao HM, "TGF-β1869T", C polymorphism and ischemic stroke: sex difference in Chinese, 2010, pp.37, 803~807
- Leu HB, "Genetic variants of connexin37 are associated with carotid intima-medial thickness and future onset of ischemic stroke", Atherosclerosis, 214, pp.101~106 (2011)
- Munshi A, "Interleukin-10-1082promoter polymorphism and ischemic stroke risk in a South Indian population", Cytokine, 52, pp.221~224 (2010)
- Conway EM, "Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxiainduced up-regulation", Am J Pathol, 163, pp.935~946 (2003)
- Broughton BR, "Apoptotic mechanisms after cerebral ischemia", Stroke, 40, pp.e331~e339 (2009)
- Sairanen T, "Apoptosis dominant in the periinfarct area of human ischaemic stroke: a possible target of antiapoptotic treatments", Brain, 129(Pt 1), pp.189~199 (2006)
- Granger CV, "Stroke rehabilitation: analysis of repeated Barthel index measures", Arch Phys Med Rehabil, 60, pp.14~17 (1979)
- Adams HP Jr, "Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)", Neurology, 53, pp.126~131 (1999)
- Zhu Y, "Association of surviving polymorphisms with tumor susceptibility: a meta-analysis", PLoS One, 8, pp.e74778~ (2013)
- Hata J, "Genome-wide association study for ischemic stroke based on the Hisayama study", Nihon Eiseigaku Zasshi, 66, pp.47~52 (2011)
- Kubo M, "Genetic risk factors of ischemic stroke identified by a genome-wide association study", Brain Nerve, 60, pp.1339~1346 (2008)
- Sun L, "Chromosome 4q25 variants rs2200733, rs10033464, and rs1906591 contribute to ischemic stroke risk", Mol Neurobiol (2015)[DOI]
- Cao YY, "Rs2200733and rs10033464 on chromosome 4q25 confer risk of cardioembolic stroke: an updated meta-analysis", Mol Biol Rep, 40, pp.5977~5985 (2013)
- Doyle KP, "Mechanisms of ischemic brain damage", Neuropharmacology, 55, pp.310~318 (2008)
- Sugawara T, "Neuronal death", survival signaling pathways in cerebral ischemia, 2004, pp.1, 17~25
- Zhang SJ, "A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage", J Neurosci, 31, pp.4978~4990 (2011)
- Li F, "Control of apoptosis and mitotic spindle checkpoint by survivin", Nature, 396, pp.580~584 (1998)
- Yamamoto T, "The role of survivin as a new target of diagnosis and treatment in human cancer", Med Electron Microsc, 34, pp.207~212 (2001)
- Han CH, "Polymorphisms in the surviving promoter are associated with age of onset of ovarian cancer", Int J Clin Exp Med, 2, pp.289~299 (2009)
- Dai J, "Prognostic significance of survivin polymorphisms on nonsmall cell lung cancer survival", J Thorac Oncol, 5, pp.1748~1754 (2010)
- Delvaeye M, "Role of the 2 zebrafish survivin genes in vasculo-angiogenesis, neurogenesis, cardiogenesis and hematopoiesis", BMC Dev Biol, 9, pp.25~ (2009)
- Li F, "Role of the Survivin gene in pathophysiology", Am J Pathol, 169, pp.1~11 (2006)
- Wang H, "Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity", J Biol Chem, 285, pp.36129~36137 (2010)
- Sehara Y, "Survivin is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemia", J Neurosci, 33, pp.12364~12374 (2013)
- Mallolas J, "A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke", Neuromolecular Med, 16, pp.856~861 (2014)